Detailed Result for NCT04669626

NCT ID: NCT04669626
NLM Download Date Description: N/A
Study First Submitted Date: 2020-12-09
Last Update Submitted Date: 2021-09-21
Last Update Submitted Date: 2021-09-21
Result First Submitted Date: N/A
Disposition First Submitted Date: N/A
Start Month Year: July 1, 2020
Start Date: 2020-07-01
Start Date Type: Actual
Verification Month Year: September 2021
Verification Date: 2021-09-30
Completion Month Year: December 31, 2021
Completion Date: 2021-12-31
Completion Date Type: Anticipated
Primary Completion Month Year: November 30, 2021
Primary Completion Date: 2021-11-30
Primary Completion Date Type: Anticipated
Study first Submitted QC Date: 2020-12-09
Study first posted Date: 2020-12-17
Result first Submitted QC Date: N/A
Result First Posted Date: N/A
Disposition First Submitted QC Date: N/A
Disposition First Posted Date: N/A
Last Updated Submitted QC Date: 2021-09-21
Last Updated Posted Date: 2021-09-22
Target Duration: N/A
Study Type: Interventional
Acronym: Odour
Baseline Population: N/A
Brief Title: The Ability of Octenilin® to Reduce Odour of Malodorous Wound
Official Title: The Ability of Octenilin® to Reduce Odour of Malodorous Wound - a Single-center Randomized Double Blinded Controlled Pilot Study
Overall Status: Recruiting
Last Known Status: N/A
Phase: Not Applicable
Enrollment: 20
Enrollment Type: Anticipated
Source: School of Health Sciences Geneva
Limitation and Caveats: N/A
Number of Arms: 2
Number of Groups: N/A
Why Stopped: N/A
Has Expanded Access: N/A
Expanded Access Type Individual: N/A
Expanded Access Type Intermediate: N/A
Expanded Access Type Treatment: N/A
Has DMC: true
Is it FDA Regulated Drug: N/A
Is it FDA Regulated Device: N/A
Is it Unapproved Device: N/A
Is US Export: N/A
Is Biospec Retention: N/A
Biospec Description: N/A
Plan to Share IPD: No
Plan to Share IPD Description: data will be ananymised
IPD Time Frame: N/A
IPD Access Criteria: N/A
© 2023 MedicalDeviceHub, LLC